Oral Pimonidazole HCl as Tumor Hypoxia Marker: Report of First Clinical Use - Pharmacokinetics and Tolerance

Saved in:
Bibliographic Details
Published in:International journal of radiation oncology, biology, physics Vol. 75; no. 3; pp. S539 - S540
Main Authors: Varia, M.A, Lee, D.Y.W, Raleigh, J.A
Format: Journal Article
Language:English
Published: Elsevier Inc 2009
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Author Raleigh, J.A
Varia, M.A
Lee, D.Y.W
Author_xml – sequence: 1
  fullname: Varia, M.A
– sequence: 2
  fullname: Lee, D.Y.W
– sequence: 3
  fullname: Raleigh, J.A
BookMark eNqFkU1LAzEQhoMo2FZ_gpA_sOtks58eFCnWCpUWbcFbSJNZzHZ3U5JWrL_eXdqTF09zmfdh3meG5Ly1LRJywyBkwNLbKjSVs-ttGAEUIWQhi3h0RgYsz4qAJ8nHORkATyHg3fYlGXpfAQBjWTwg9dzJmi5MY1uj5Y-tkU7HNZWeLveNdXR62NpvI-mrdBt0d_QNt9btqC3pxDi_o-PatEZ1iJVHGtDFp3SNVHZjWtwZ5alsNV12VCdbhVfkopS1x-vTHJHV5Gk5ngaz-fPL-HEWKJZkUSAlZnEap6jylGeM6wJYWTJIc60TqZJijZp33RLGJEgFcar0uoiLknO1LlnORyQ5cpWz3jssxdaZRrqDYCB6ZaISR2WiVyYgE72yLvdwzGF33JdBJ7wy2B2ujUO1E9qafwn3fwjqJGiDB_SV3bu2ay6Y8JEA8d6_pf8KFBBFWcz5L9xYjh4
ContentType Journal Article
Copyright Elsevier Inc.
2009 Elsevier Inc.
Copyright_xml – notice: Elsevier Inc.
– notice: 2009 Elsevier Inc.
DBID AAYXX
CITATION
DOI 10.1016/j.ijrobp.2009.07.1232
DatabaseName CrossRef
DatabaseTitle CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1879-355X
EndPage S540
ExternalDocumentID 10_1016_j_ijrobp_2009_07_1232
S0360301609022743
1_s2_0_S0360301609022743
GroupedDBID ---
--K
.1-
.55
.FO
.GJ
0R~
1B1
1P~
1RT
1~5
29J
4.4
457
4G.
53G
5RE
5VS
7-5
AAEDT
AAEDW
AALRI
AAQFI
AAQQT
AAQXK
AAWTL
AAXUO
ABEFU
ABJNI
ABLJU
ABNEU
ABOCM
ABUDA
ACGFS
ACIUM
ADBBV
ADMUD
ADPAM
ADVLN
AENEX
AEVXI
AFCTW
AFFNX
AFJKZ
AFRHN
AFTJW
AGRDE
AHHHB
AITUG
AJUYK
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ASPBG
AVWKF
AZFZN
BELOY
DU5
EBS
EFJIC
EJD
F5P
FDB
FEDTE
FGOYB
FIRID
G-2
GBLVA
HED
HMK
HMO
HVGLF
HX~
HZ~
IHE
J1W
KOM
LX3
M41
MO0
NQ-
O9-
OC~
OO-
R2-
RIG
RNS
ROL
RPZ
SAE
SDG
SEL
SES
SEW
SSZ
UDS
UV1
X7M
XH2
XPP
Z5R
ZGI
~S-
AAIAV
AGZHU
AHPSJ
ALXNB
ZA5
AAYXX
CITATION
ID FETCH-LOGICAL-c1572-aae74646ec863713d901ff1068dd5ac59bed3879511a0ac046cdb949f33cbf183
ISSN 0360-3016
IngestDate Thu Sep 26 19:30:09 EDT 2024
Fri Feb 23 02:25:33 EST 2024
Tue Oct 15 22:55:28 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c1572-aae74646ec863713d901ff1068dd5ac59bed3879511a0ac046cdb949f33cbf183
ParticipantIDs crossref_primary_10_1016_j_ijrobp_2009_07_1232
elsevier_sciencedirect_doi_10_1016_j_ijrobp_2009_07_1232
elsevier_clinicalkeyesjournals_1_s2_0_S0360301609022743
PublicationCentury 2000
PublicationDate 2009
PublicationDateYYYYMMDD 2009-01-01
PublicationDate_xml – year: 2009
  text: 2009
PublicationDecade 2000
PublicationTitle International journal of radiation oncology, biology, physics
PublicationYear 2009
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
SSID ssj0001174
Score 1.9474957
SourceID crossref
elsevier
SourceType Aggregation Database
Publisher
StartPage S539
SubjectTerms Hematology, Oncology and Palliative Medicine
Radiology
Title Oral Pimonidazole HCl as Tumor Hypoxia Marker: Report of First Clinical Use - Pharmacokinetics and Tolerance
URI https://www.clinicalkey.es/playcontent/1-s2.0-S0360301609022743
https://dx.doi.org/10.1016/j.ijrobp.2009.07.1232
Volume 75
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6lRUJcEE8RXtoDt8jG67e5VWmqXApVk0LhstqXpYQSVzaRgF_PrPfh0FYIkLhY0cqv7HzZ-XYy8w1Cr8qIq5TUVcCUUEGq82g4y3gQ50LkUSVJ3JeLzRfF2_PycJbORiPXE28Y-6-WhjGwta6c_Qtr-5vCAHwGm8MRrA7HP7L7O11xfwIW2Kwk-6FzB-fTC91NZrn90rST-ffL5tuK9TU6qjXpcJqCa9J4tAIqOJm6WsmzTk2CyYnVtv4MdNRLOi_hvq3Hy3rIhh-CizuSFK3WPzDMdCN8dQwfCmVMeMWz-_ewf-857XF4EF7JGDoMP4Yf_OAp60O7PRTduS6EMSyRvqrml6RPcKrgGyJiJbLNwlwWVQDc6Hx35TY9VyxCk51leJEZhSTr0heZkYS65i5M5GIdrtZtw516aRFqmjn4R5-1uNAvpt9L57LCbj7ZQ7diWN90y4ZP2aknAMSKf7uvMRSOvb7xUTdToh2as7yH7tr9CT4wwLqPRmrzAN0-thkYD9GFxhfexRcGfGHW4R5f2OILG3y9wQZduKlxjy7s0IUBXTjAV9GFAV3Yo-sROjuaLafzwHbsCATJijhgTBVpnuZKlHlSkEQC26xrEuWllBkTWcWVTHR7e0JYxESU5kLyKq3qJBG8Bu_yGO1vmo16gjDsRLTUXSUknBapmHNZSK6qGjYYJI7SMQrdpNFLI8xCXcbimppZ1j1WKxoVVM_yGBVuaqmrOgY_qTr7e-gooV1MI3rNzGNU-istLzV8kwKOfv_Qp_9-6TN0x_xzqcN9z9H-13arXqC9Tm5f9nD7CbAEsJg
link.rule.ids 315,782,786,4030,27934,27935,27936
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Oral+Pimonidazole+HCl+as+Tumor+Hypoxia+Marker%3A+Report+of+First+Clinical+Use+-+Pharmacokinetics+and+Tolerance&rft.jtitle=International+journal+of+radiation+oncology%2C+biology%2C+physics&rft.au=Varia%2C+M.A.&rft.au=Lee%2C+D.Y.W.&rft.au=Raleigh%2C+J.A.&rft.date=2009&rft.pub=Elsevier+Inc&rft.issn=0360-3016&rft.eissn=1879-355X&rft.volume=75&rft.issue=3&rft.spage=S539&rft.epage=S540&rft_id=info:doi/10.1016%2Fj.ijrobp.2009.07.1232&rft.externalDocID=S0360301609022743
thumbnail_m http://sdu.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F03603016%2FS0360301609X00155%2Fcov150h.gif